Business
LEVBIO: Improved margins and reduced losses signal a turnaround, but liquidity remains a key risk
LEVBIO: Improved margins and reduced losses signal a turnaround, but liquidity remains a key risk
About this update from Level Bio Ab
2024 saw a strategic turnaround with improved gross margin and reduced losses despite a slight revenue decline. Investments in systems and rebranding, new supplier agreements, and a successful share issue set the stage for future growth, though liquidity and market risks remain.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.